SAN MATEO, Calif.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the launch of the EsophyX®2 HD (high definition), the latest-generation of the company’s EsophyX® platform.
The new system allows surgeons and gastroenterologists to use a wider selection of endoscopes--including larger high-definition versions—when performing Transoral Incisionless Fundoplication (TIF®) procedures to treat the underlying anatomical causes of GERD.
Hey, check out all the research scientist jobs. Post your resume today!
